New trends in Staphylococcus aureus infections: glycopeptide resistance in hospital and methicillin resistance in the community
K Hiramatsu, K Okuma, XX Ma… - Current opinion in …, 2002 - journals.lww.com
K Hiramatsu, K Okuma, XX Ma, M Yamamoto, S Hori, M Kapi
Current opinion in infectious diseases, 2002•journals.lww.comThe references given here (excluding some of low credibility) attest the increasing
awareness of the two conspicuous problems concerning methicillin-resistant S. aureus
infection. One is the increasing trend of glycopeptide-resistance, making difficult the
successful treatment of multi-drug-resistant methicillin-resistant S. aureus infection in the
hospital. On the other hand, non-multi-drug-resistant methicillin-resistant S. aureus strains
are emerging as novel threats in the community, the genetic analysis of which indicates that …
awareness of the two conspicuous problems concerning methicillin-resistant S. aureus
infection. One is the increasing trend of glycopeptide-resistance, making difficult the
successful treatment of multi-drug-resistant methicillin-resistant S. aureus infection in the
hospital. On the other hand, non-multi-drug-resistant methicillin-resistant S. aureus strains
are emerging as novel threats in the community, the genetic analysis of which indicates that …
Summary
The references given here (excluding some of low credibility) attest the increasing awareness of the two conspicuous problems concerning methicillin-resistant S. aureus infection. One is the increasing trend of glycopeptide-resistance, making difficult the successful treatment of multi-drug-resistant methicillin-resistant S. aureus infection in the hospital. On the other hand, non-multi-drug-resistant methicillin-resistant S. aureus strains are emerging as novel threats in the community, the genetic analysis of which indicates that they are independent clones from those found in hospitals.
Lippincott Williams & Wilkins